Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Lymphatic regulator PROX1 determines Schlemm’s canal integrity and identity

Identifieur interne : 002F24 ( Pmc/Corpus ); précédent : 002F23; suivant : 002F25

Lymphatic regulator PROX1 determines Schlemm’s canal integrity and identity

Auteurs : Dae-Young Park ; Junyeop Lee ; Intae Park ; Dongwon Choi ; Sunju Lee ; Sukhyun Song ; Yoonha Hwang ; Ki Yong Hong ; Yoshikazu Nakaoka ; Taija Makinen ; Pilhan Kim ; Kari Alitalo ; Young-Kwon Hong ; Gou Young Koh

Source :

RBID : PMC:4153702

Abstract

Schlemm’s canal (SC) is a specialized vascular structure in the eye that functions to drain aqueous humor from the intraocular chamber into systemic circulation. Dysfunction of SC has been proposed to underlie increased aqueous humor outflow (AHO) resistance, which leads to elevated ocular pressure, a factor for glaucoma development in humans. Here, using lymphatic and blood vasculature reporter mice, we determined that SC, which originates from blood vessels during the postnatal period, acquires lymphatic identity through upregulation of prospero homeobox protein 1 (PROX1), the master regulator of lymphatic development. SC expressed lymphatic valve markers FOXC2 and integrin α9 and exhibited continuous vascular endothelial–cadherin (VE-cadherin) junctions and basement membrane, similar to collecting lymphatics. SC notably lacked luminal valves and expression of the lymphatic endothelial cell markers podoplanin and lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1). Using an ocular puncture model, we determined that reduced AHO altered the fate of SC both during development and under pathologic conditions; however, alteration of VEGF-C/VEGFR3 signaling did not modulate SC integrity and identity. Intriguingly, PROX1 expression levels linearly correlated with SC functionality. For example, PROX1 expression was reduced or undetectable under pathogenic conditions and in deteriorated SCs. Collectively, our data indicate that PROX1 is an accurate and reliable biosensor of SC integrity and identity.


Url:
DOI: 10.1172/JCI75392
PubMed: 25061877
PubMed Central: 4153702

Links to Exploration step

PMC:4153702

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Lymphatic regulator PROX1 determines Schlemm’s canal integrity and identity</title>
<author>
<name sortKey="Park, Dae Young" sort="Park, Dae Young" uniqKey="Park D" first="Dae-Young" last="Park">Dae-Young Park</name>
<affiliation>
<nlm:aff id="JCI75392">National Research Laboratory of Vascular Biology and Stem Cells, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Lee, Junyeop" sort="Lee, Junyeop" uniqKey="Lee J" first="Junyeop" last="Lee">Junyeop Lee</name>
<affiliation>
<nlm:aff id="JCI75392">National Research Laboratory of Vascular Biology and Stem Cells, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Park, Intae" sort="Park, Intae" uniqKey="Park I" first="Intae" last="Park">Intae Park</name>
<affiliation>
<nlm:aff id="JCI75392">National Research Laboratory of Vascular Biology and Stem Cells, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Choi, Dongwon" sort="Choi, Dongwon" uniqKey="Choi D" first="Dongwon" last="Choi">Dongwon Choi</name>
<affiliation>
<nlm:aff id="JCI75392">Department of Surgery, Department of Biochemistry and Molecular Biology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Lee, Sunju" sort="Lee, Sunju" uniqKey="Lee S" first="Sunju" last="Lee">Sunju Lee</name>
<affiliation>
<nlm:aff id="JCI75392">Department of Surgery, Department of Biochemistry and Molecular Biology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Song, Sukhyun" sort="Song, Sukhyun" uniqKey="Song S" first="Sukhyun" last="Song">Sukhyun Song</name>
<affiliation>
<nlm:aff id="JCI75392">National Research Laboratory of Vascular Biology and Stem Cells, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Hwang, Yoonha" sort="Hwang, Yoonha" uniqKey="Hwang Y" first="Yoonha" last="Hwang">Yoonha Hwang</name>
<affiliation>
<nlm:aff id="JCI75392">Graduate School of Nanoscience and Technology, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Hong, Ki Yong" sort="Hong, Ki Yong" uniqKey="Hong K" first="Ki Yong" last="Hong">Ki Yong Hong</name>
<affiliation>
<nlm:aff id="JCI75392">National Research Laboratory of Vascular Biology and Stem Cells, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Nakaoka, Yoshikazu" sort="Nakaoka, Yoshikazu" uniqKey="Nakaoka Y" first="Yoshikazu" last="Nakaoka">Yoshikazu Nakaoka</name>
<affiliation>
<nlm:aff id="JCI75392">Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Makinen, Taija" sort="Makinen, Taija" uniqKey="Makinen T" first="Taija" last="Makinen">Taija Makinen</name>
<affiliation>
<nlm:aff id="JCI75392">Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Kim, Pilhan" sort="Kim, Pilhan" uniqKey="Kim P" first="Pilhan" last="Kim">Pilhan Kim</name>
<affiliation>
<nlm:aff id="JCI75392">Graduate School of Nanoscience and Technology, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Alitalo, Kari" sort="Alitalo, Kari" uniqKey="Alitalo K" first="Kari" last="Alitalo">Kari Alitalo</name>
<affiliation>
<nlm:aff id="JCI75392">Molecular/Cancer Biology Laboratory, Biomedicum Helsinki, Department of Pathology, Haartman Institute and Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Hong, Young Kwon" sort="Hong, Young Kwon" uniqKey="Hong Y" first="Young-Kwon" last="Hong">Young-Kwon Hong</name>
<affiliation>
<nlm:aff id="JCI75392">Department of Surgery, Department of Biochemistry and Molecular Biology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Koh, Gou Young" sort="Koh, Gou Young" uniqKey="Koh G" first="Gou Young" last="Koh">Gou Young Koh</name>
<affiliation>
<nlm:aff id="JCI75392">National Research Laboratory of Vascular Biology and Stem Cells, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">25061877</idno>
<idno type="pmc">4153702</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153702</idno>
<idno type="RBID">PMC:4153702</idno>
<idno type="doi">10.1172/JCI75392</idno>
<date when="2014">2014</date>
<idno type="wicri:Area/Pmc/Corpus">002F24</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002F24</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Lymphatic regulator PROX1 determines Schlemm’s canal integrity and identity</title>
<author>
<name sortKey="Park, Dae Young" sort="Park, Dae Young" uniqKey="Park D" first="Dae-Young" last="Park">Dae-Young Park</name>
<affiliation>
<nlm:aff id="JCI75392">National Research Laboratory of Vascular Biology and Stem Cells, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Lee, Junyeop" sort="Lee, Junyeop" uniqKey="Lee J" first="Junyeop" last="Lee">Junyeop Lee</name>
<affiliation>
<nlm:aff id="JCI75392">National Research Laboratory of Vascular Biology and Stem Cells, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Park, Intae" sort="Park, Intae" uniqKey="Park I" first="Intae" last="Park">Intae Park</name>
<affiliation>
<nlm:aff id="JCI75392">National Research Laboratory of Vascular Biology and Stem Cells, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Choi, Dongwon" sort="Choi, Dongwon" uniqKey="Choi D" first="Dongwon" last="Choi">Dongwon Choi</name>
<affiliation>
<nlm:aff id="JCI75392">Department of Surgery, Department of Biochemistry and Molecular Biology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Lee, Sunju" sort="Lee, Sunju" uniqKey="Lee S" first="Sunju" last="Lee">Sunju Lee</name>
<affiliation>
<nlm:aff id="JCI75392">Department of Surgery, Department of Biochemistry and Molecular Biology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Song, Sukhyun" sort="Song, Sukhyun" uniqKey="Song S" first="Sukhyun" last="Song">Sukhyun Song</name>
<affiliation>
<nlm:aff id="JCI75392">National Research Laboratory of Vascular Biology and Stem Cells, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Hwang, Yoonha" sort="Hwang, Yoonha" uniqKey="Hwang Y" first="Yoonha" last="Hwang">Yoonha Hwang</name>
<affiliation>
<nlm:aff id="JCI75392">Graduate School of Nanoscience and Technology, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Hong, Ki Yong" sort="Hong, Ki Yong" uniqKey="Hong K" first="Ki Yong" last="Hong">Ki Yong Hong</name>
<affiliation>
<nlm:aff id="JCI75392">National Research Laboratory of Vascular Biology and Stem Cells, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Nakaoka, Yoshikazu" sort="Nakaoka, Yoshikazu" uniqKey="Nakaoka Y" first="Yoshikazu" last="Nakaoka">Yoshikazu Nakaoka</name>
<affiliation>
<nlm:aff id="JCI75392">Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Makinen, Taija" sort="Makinen, Taija" uniqKey="Makinen T" first="Taija" last="Makinen">Taija Makinen</name>
<affiliation>
<nlm:aff id="JCI75392">Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Kim, Pilhan" sort="Kim, Pilhan" uniqKey="Kim P" first="Pilhan" last="Kim">Pilhan Kim</name>
<affiliation>
<nlm:aff id="JCI75392">Graduate School of Nanoscience and Technology, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Alitalo, Kari" sort="Alitalo, Kari" uniqKey="Alitalo K" first="Kari" last="Alitalo">Kari Alitalo</name>
<affiliation>
<nlm:aff id="JCI75392">Molecular/Cancer Biology Laboratory, Biomedicum Helsinki, Department of Pathology, Haartman Institute and Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Hong, Young Kwon" sort="Hong, Young Kwon" uniqKey="Hong Y" first="Young-Kwon" last="Hong">Young-Kwon Hong</name>
<affiliation>
<nlm:aff id="JCI75392">Department of Surgery, Department of Biochemistry and Molecular Biology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Koh, Gou Young" sort="Koh, Gou Young" uniqKey="Koh G" first="Gou Young" last="Koh">Gou Young Koh</name>
<affiliation>
<nlm:aff id="JCI75392">National Research Laboratory of Vascular Biology and Stem Cells, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.</nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">The Journal of Clinical Investigation</title>
<idno type="ISSN">0021-9738</idno>
<idno type="eISSN">1558-8238</idno>
<imprint>
<date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>Schlemm’s canal (SC) is a specialized vascular structure in the eye that functions to drain aqueous humor from the intraocular chamber into systemic circulation. Dysfunction of SC has been proposed to underlie increased aqueous humor outflow (AHO) resistance, which leads to elevated ocular pressure, a factor for glaucoma development in humans. Here, using lymphatic and blood vasculature reporter mice, we determined that SC, which originates from blood vessels during the postnatal period, acquires lymphatic identity through upregulation of prospero homeobox protein 1 (PROX1), the master regulator of lymphatic development. SC expressed lymphatic valve markers FOXC2 and integrin α
<sub>9</sub>
and exhibited continuous vascular endothelial–cadherin (VE-cadherin) junctions and basement membrane, similar to collecting lymphatics. SC notably lacked luminal valves and expression of the lymphatic endothelial cell markers podoplanin and lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1). Using an ocular puncture model, we determined that reduced AHO altered the fate of SC both during development and under pathologic conditions; however, alteration of VEGF-C/VEGFR3 signaling did not modulate SC integrity and identity. Intriguingly, PROX1 expression levels linearly correlated with SC functionality. For example, PROX1 expression was reduced or undetectable under pathogenic conditions and in deteriorated SCs. Collectively, our data indicate that PROX1 is an accurate and reliable biosensor of SC integrity and identity.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article">
<pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Clin Invest</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Clin. Invest</journal-id>
<journal-id journal-id-type="publisher-id">J CLIN INVEST</journal-id>
<journal-title-group>
<journal-title>The Journal of Clinical Investigation</journal-title>
</journal-title-group>
<issn pub-type="ppub">0021-9738</issn>
<issn pub-type="epub">1558-8238</issn>
<publisher>
<publisher-name>American Society for Clinical Investigation</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">25061877</article-id>
<article-id pub-id-type="pmc">4153702</article-id>
<article-id pub-id-type="publisher-id">75392</article-id>
<article-id pub-id-type="doi">10.1172/JCI75392</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Lymphatic regulator PROX1 determines Schlemm’s canal integrity and identity</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Park</surname>
<given-names>Dae-Young</given-names>
</name>
<xref ref-type="aff" rid="JCI75392">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Junyeop</given-names>
</name>
<xref ref-type="aff" rid="JCI75392">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Park</surname>
<given-names>Intae</given-names>
</name>
<xref ref-type="aff" rid="JCI75392">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Choi</surname>
<given-names>Dongwon</given-names>
</name>
<xref ref-type="aff" rid="JCI75392">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Sunju</given-names>
</name>
<xref ref-type="aff" rid="JCI75392">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Song</surname>
<given-names>Sukhyun</given-names>
</name>
<xref ref-type="aff" rid="JCI75392">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hwang</surname>
<given-names>Yoonha</given-names>
</name>
<xref ref-type="aff" rid="JCI75392">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hong</surname>
<given-names>Ki Yong</given-names>
</name>
<xref ref-type="aff" rid="JCI75392">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nakaoka</surname>
<given-names>Yoshikazu</given-names>
</name>
<xref ref-type="aff" rid="JCI75392">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Makinen</surname>
<given-names>Taija</given-names>
</name>
<xref ref-type="aff" rid="JCI75392">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Pilhan</given-names>
</name>
<xref ref-type="aff" rid="JCI75392">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alitalo</surname>
<given-names>Kari</given-names>
</name>
<xref ref-type="aff" rid="JCI75392">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hong</surname>
<given-names>Young-Kwon</given-names>
</name>
<xref ref-type="aff" rid="JCI75392">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Koh</surname>
<given-names>Gou Young</given-names>
</name>
<xref ref-type="aff" rid="JCI75392">1</xref>
</contrib>
</contrib-group>
<aff id="JCI75392">
<label>1</label>
National Research Laboratory of Vascular Biology and Stem Cells, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.
<label>2</label>
Department of Surgery, Department of Biochemistry and Molecular Biology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
<label>3</label>
Graduate School of Nanoscience and Technology, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.
<label>4</label>
Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
<label>5</label>
Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
<label>6</label>
Molecular/Cancer Biology Laboratory, Biomedicum Helsinki, Department of Pathology, Haartman Institute and Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.</aff>
<author-notes>
<corresp>Address correspondence to: Gou Young Koh, Graduate School of Medical Science and Engineering, KAIST, 373-1, Guseong-dong, Daejeon, 305-701, Korea. Phone: 82.42.350.2638; E-mail:
<email>gykoh@kaist.ac.kr</email>
. Or to: Young Kwon Hong, Departments of Surgery and of Biochemistry & Molecular Biology, Keck School of Medicine, University of Southern California, 1450 Biggy St., Los Angeles, California 90033, USA. Phone: 323.442.7825; E-mail:
<email>young.hong@usc.edu</email>
.</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>25</day>
<month>7</month>
<year>2014</year>
</pub-date>
<pub-date pub-type="ppub">
<day>2</day>
<month>9</month>
<year>2014</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>25</day>
<month>7</month>
<year>2014</year>
</pub-date>
<pmc-comment> PMC Release delay is 0 months and 0 days and was based on the . </pmc-comment>
<volume>124</volume>
<issue>9</issue>
<fpage>3960</fpage>
<lpage>3974</lpage>
<history>
<date date-type="received">
<day>27</day>
<month>1</month>
<year>2014</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>5</month>
<year>2014</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2014, American Society for Clinical Investigation</copyright-statement>
<copyright-year>2014</copyright-year>
<copyright-holder>American Society for Clinical Investigation</copyright-holder>
</permissions>
<abstract>
<p>Schlemm’s canal (SC) is a specialized vascular structure in the eye that functions to drain aqueous humor from the intraocular chamber into systemic circulation. Dysfunction of SC has been proposed to underlie increased aqueous humor outflow (AHO) resistance, which leads to elevated ocular pressure, a factor for glaucoma development in humans. Here, using lymphatic and blood vasculature reporter mice, we determined that SC, which originates from blood vessels during the postnatal period, acquires lymphatic identity through upregulation of prospero homeobox protein 1 (PROX1), the master regulator of lymphatic development. SC expressed lymphatic valve markers FOXC2 and integrin α
<sub>9</sub>
and exhibited continuous vascular endothelial–cadherin (VE-cadherin) junctions and basement membrane, similar to collecting lymphatics. SC notably lacked luminal valves and expression of the lymphatic endothelial cell markers podoplanin and lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1). Using an ocular puncture model, we determined that reduced AHO altered the fate of SC both during development and under pathologic conditions; however, alteration of VEGF-C/VEGFR3 signaling did not modulate SC integrity and identity. Intriguingly, PROX1 expression levels linearly correlated with SC functionality. For example, PROX1 expression was reduced or undetectable under pathogenic conditions and in deteriorated SCs. Collectively, our data indicate that PROX1 is an accurate and reliable biosensor of SC integrity and identity.</p>
</abstract>
</article-meta>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002F24 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 002F24 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     PMC:4153702
   |texte=   Lymphatic regulator PROX1 determines Schlemm’s canal integrity and
identity
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i   -Sk "pubmed:25061877" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024